DMK Pharmaceuticals Corp (NASDAQ:DMK)
| 0.6906 Delayed Data As of Sep 29 |  +0.034 / +5.18%Today’s Change | 0.45 Today|||52-Week Range 21.70 | -94.17% Year-to-Date |
Latest DMK News | Press Releases
No recent news for DMK Pharmaceuticals Corp.
Today’s Trading
| Previous close | 0.66 |
| Today’s open | 0.63 |
| Day’s range | 0.60 - 0.73 |
| Volume | 17,008 |
| Average volume (3 months) | 2,272,451 |
| Market cap | $5.7M |
Data as of 3:59pm ET, 09/29/2023
Growth & Valuation
| Earnings growth (last year) | +44.42% |
| Earnings growth (this year) | +55.56% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | +115.34% |
| P/E ratio | NM |
| Price/Sales | 5.33 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --ValiRx PLC | 0.00 | 0.00% |
| ATXIAvenue Therapeutics ... | +0.04 | +5.66% |
| ALRNAileron Therapeutics... | -0.03 | -1.97% |
| KTRAKintara Therapeutics... | +0.07 | +1.76% |
Data as of 3:59pm ET, 09/29/2023
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $4.8M |
| Annual profit (last year) | -$26.5M |
| Net profit margin | -550.86% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
